
Orgenesis
(OTC) ORGS
Orgenesis Financials at a Glance
Market Cap
$1.29M
Revenue (TTM)
$12.87M
Net Income (TTM)
$43.94M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
232.61 (High)
Dividend
$0.00
Beta (Volatility)
232.61 (High)
Price
$0.25
Volume
100
Open
$0.25
Price
$0.25
Volume
100
Open
$0.25
Previous Close
$0.25
Daily Range
$0.25 - $0.25
52-Week Range
$0.00 - $4.00
Dividend
$0.00
Beta (Volatility)
232.61 (High)
Price
$0.25
Volume
100
Open
$0.25
Previous Close
$0.25
Daily Range
$0.25 - $0.25
52-Week Range
$0.00 - $4.00
ORGS News
ORGS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Orgenesis
Industry
Biotechnology
Sector
Health CareEmployees
146
CEO
Vered Caplan
Website
www.orgenesis.comHeadquarters
Germantown, MD 20876, US
ORGS Financials
Key Financial Metrics (TTM)
Gross Margin
-11%
Operating Margin
-101%
Net Income Margin
-104%
Return on Equity
0%
Return on Capital
29%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.29M
Shares Outstanding
5.17M
Volume
100
Short Interest
0.00%
Avg. Volume
962.016
Financials (TTM)
Gross Profit
$5.72M
Operating Income
$53.64M
EBITDA
$60.72M
Operating Cash Flow
$14.84M
Capital Expenditure
$2.10M
Free Cash Flow
$16.93M
Cash & ST Invst.
$837.00K
Total Debt
$22.62M
Orgenesis Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$347.00K
+215.5%
Gross Profit
$238.00K
-720.7%
Gross Margin
-68.59%
N/A
Market Cap
$1.29M
N/A
Market Cap/Employee
$8.85K
N/A
Employees
146
N/A
Net Income
$9.12M
+344.8%
EBITDA
$7.66M
-203.0%
Quarterly Fundamentals
Net Cash
$17.09M
+21.2%
Accounts Receivable
$1.40M
+24.4%
Inventory
$0.00
-100.0%
Long Term Debt
$10.10M
-45.5%
Short Term Debt
$7.19M
+124.3%
Return on Assets
-3.80%
N/A
Return on Invested Capital
28.91%
N/A
Free Cash Flow
$4.69M
-216.5%
Operating Cash Flow
$4.63M
-292.0%